Live Breaking News & Updates on Kurma partners

Stay informed with the latest breaking news from Kurma partners on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Kurma partners and stay connected to the pulse of your community

Memo Therapeutics increases Series C financing to CHF 45 million

Memo Therapeutics increases Series C financing to CHF 45 million
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Switzerland , Barcelona , Comunidad-autonoma-de-cataluna , Spain , Zurich , Züsz , Spanish , Hadrien-bouchez , Amber-fennell , Ashley-tapp , Thomas-harth , Pureos-bioventures

Memo Therapeutics Raises CHF 20M; Increases Series C to CHF 45M

Memo Therapeutics Raises CHF 20M; Increases Series C to CHF 45M
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Zurich , Züsz , Switzerland , Pureos-bioventures , Thomas-harth , Hadrien-bouchez , Gf-group , Memo-therapeutics , Ysios-capital , Kurma-partners , Vesalius-biocapital , Adjuvant-capital

Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium

Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium Two key presentations by leading KOLs highlight positive results from aXess trials in adult patients with end-stage renal disease who need vascular access to hemodialysisaXess is a restorative arteriovenous...

United-states , Germany , Hamburg , Netherlands , London , City-of , United-kingdom , Charing-cross , Westminster , Alexander-goemans , Joshua-evans , Eliane-schutte

Vivet Therapeutics Doses First Patient in Cohort 2 in Phase 1/2 GATEWAY Clinical Trial for Treatment of Wilson Disease

Vivet Therapeutics Doses First Patient in Cohort 2 in Phase 1/2 GATEWAY Clinical Trial for Treatment of Wilson Disease
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Denmark , Niew , Lóie , Poland , Paris , France-general- , France , United-kingdom , Germany , Leboucher , Centre , Michael-schilsky

Rare Disease Day 2024 - Call for greater awareness of X-linked adrenoleukodystrophy and cerebral adrenoleukodystrophy

/PRNewswire/ -- Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS)...

United-states , Spain , Barcelona , Comunidad-autonoma-de-cataluna , Belgium , Germany , Paris , France-general- , France , Belgian , America , Karen-harrison

Neuraxpharm: Rare Disease Day 2024 - Call for greater awareness of X-linked adrenoleukodystrophy and cerebral adrenoleukodystrophy

Neuraxpharm: Rare Disease Day 2024 - Call for greater awareness of X-linked adrenoleukodystrophy and cerebral adrenoleukodystrophy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China , Lesen , Aquitaine , France , Barcelona , Comunidad-autonoma-de-cataluna , Spain , Paris , France-general- , United-states , Germany , Belgium

Rare Disease Day 2024 - Call For Greater Awareness Of X-Linked Adrenoleukodystrophy And Cerebral Adrenoleukodystrophy - Special Film Launched

Rare Disease Day 2024 - Call For Greater Awareness Of X-Linked Adrenoleukodystrophy And Cerebral Adrenoleukodystrophy - Special Film Launched
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states , Germany , Paris , France-general- , France , Belgium , Barcelona , Comunidad-autonoma-de-cataluna , Spain , Belgian , America , Laboratorios-lesvi

Samsung Biologics and LegoChem enter ADC development deal

Samsung Biologics has entered into a strategic partnership with LegoChem Biosciences to advance ADC programmes aimed at treating solid tumours.

Legochem-biosciences , Samsung-biologics , Drug-administration , Samsung-life-science-fund , Samsung-biologic , Legochem-bioscience , Investigational-new-drug , Yong-zu-kim , Chem-biosciences , Kurma-partners , Kurma-partner , John-rim

Vivet Therapeutics receives EUR 4.9 million to advance development of a gene therapy for the treatment of cerebrotendinous xanthomatosis

Vivet Therapeutics receives EUR 4.9 million to advance development of a gene therapy for the treatment of cerebrotendinous xanthomatosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Paris , France-general- , France , Spain , French , Spanish , Jean-philippe-combal , Gloria-gonzalez , Stefan-klotter , Gloria-gonzalez-aseguinolaza , Pfizer-inc , France-health-innovation-plan

Vivet Therapeutics Receives EUR 4.9M Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

France , Paris , France-general- , French , Jean-philippe-combal , Gloria-gonzalez-aseguinolaza , Roche-venture-fund , France-health-innovation-plan , Novartis-venture-fund , Pfizer-inc , Vivet-therapeutics , French-government